Skip to main content
FinSpry Logo
FinSpry
CLDX logo
CLDX
(NASDAQ)
Celldex Therapeutics, Inc.
$31.06-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Celldex Therapeutics (CLDX) Stock Price & Financial Analysis

Celldex Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$28.41 - $31.39
52-Week High$34.52
52-Week Low$14.40
Open$29.31
Volume5.17M
Average Volume (3M)5.17M
Market Cap2.07B
Shares Outstanding66.50M
Price to Sales (P/S)1385.86
Price to Book (P/B)3.94
EV/EBITDA-7.38
Revenue (TTM)1.50M
Net Income (TTM)-258.80M
Free Cash Flow (TTM)-213.37M
EPS (TTM)$-3.89
Profit Margin-17253.33%
Operating Margin-19160.00%
Return on Equity (ROE)-49.09%
Debt to Equity0.00
50-Day MA$27.57
200-Day MA$25.35
52-Week Change85.52%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Celldex Therapeutics

What is the current stock price for CLDX?

As of the latest trading session, CLDX stock trades at $31.06. The 52-week range is $14.40–$34.52, with a day range of $28.41–$31.39.

What is the P/E ratio for CLDX?

The P/E ratio (Price-to-Earnings) for CLDX is shown in the Key Statistics section. This valuation metric helps compare Celldex Therapeutics, Inc. to industry peers.

Does CLDX pay dividends?

Celldex Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CLDX?

Based on 2 analysts, the consensus for CLDX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CLDX?

Celldex Therapeutics's market capitalization is $2.07B, classifying it as a mid-cap company. Celldex Therapeutics operates in the Healthcare sector within the Biotechnology industry.